4D Molecular Therapeutics FDMT
$10.23 −$0.49 (-4.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.23 0.00%
Open$10.36
Prev close$10.72
Day range$10.11 – $10.94
Volume691.0K
Market cap$576.76M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts7
Average target$29.00+183.5% vs. price
- Buy 86%
- Hold 14%
Low $20.00Now $10.23Avg $29.00High $36.00
Recent rating changes
The last 20 actions on file set price targets from $20.00 to $36.00, averaging $30.50.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 12 Nov 2026 | Goldman Sachs | BUY | $32.00 |
| 22 Oct 2026 | H.C. Wainwright | BUY | $36.00 |
| 21 Oct 2026 | BofA Securities | BUY | $33.00 |
| 21 Oct 2026 | Morgan Stanley | HOLD | – |
| 19 Oct 2026 | Cantor Fitzgerald | BUY | $20.00 |
| 13 Oct 2026 | Barclays | BUY | $28.00 |
| 6 Oct 2026 | Chardan Capital | BUY | $25.00 |
| 28 Sep 2026 | BofA Securities | BUY | $33.00 |
| 28 Sep 2026 | Morgan Stanley | HOLD | – |
| 21 Sep 2026 | Cantor Fitzgerald | BUY | – |
| 11 Sep 2026 | Barclays | BUY | $28.00 |
| 17 Aug 2026 | Morgan Stanley | HOLD | – |
| 14 Aug 2026 | BofA Securities | BUY | – |
| 14 Aug 2026 | Morgan Stanley | HOLD | – |
| 14 Aug 2026 | H.C. Wainwright | BUY | $36.00 |
| 14 Aug 2026 | RBC Capital | BUY | $35.00 |
| 20 Jul 2026 | BofA Securities | BUY | $29.00 |
| 20 Jul 2026 | Evercore | BUY | $23.00 |
| 20 Jul 2026 | Goldman Sachs | BUY | $33.00 |
| 20 Jul 2026 | H.C. Wainwright | BUY | $36.00 |
No comments yet — be the first to weigh in on FDMT.
Sign in to join the discussion.